Key result
Remote hypertension care is linked to a ~89% increase in BP goal attainment and fewer hospitalizations.
Why the study?
To evaluate whether a remote patient care hypertension program can improve clinical outcomes at scale for Medicare patients while also reducing health care costs and utilization.
Does a remote patient care hypertension program improve blood pressure control and reduce healthcare costs and utilization in Medicare patients with hypertension?
Cohort (n=7,256)
Yes
Does a remote patient care hypertension program improve blood pressure control and reduce healthcare costs and utilization in Medicare patients with hypertension?
Answers are grounded in this paper and cite their sources.
A nationwide remote patient care program for hypertension significantly improved blood pressure control and reduced inpatient healthcare utilization and costs among Medicare beneficiaries.
OBJECTIVE: To evaluate whether a remote patient care (RPC) hypertension program, which leverages remote patient monitoring and a technology-enabled, proactive care model, can not only improve clinical outcomes at scale for Medicare patients with hypertension but also reduce health care costs and utilization. PATIENTS AND METHODS: From February 1 2022 to October 31 2023, Medicare patients with hypertension were enrolled into a technology-enabled RPC hypertension program, which leveraged automatically transmitted blood pressure (BP) from a cellular-enabled BP cuff and clinical visits, to optimize patient engagement and increase BP control. Mean reduction in BP and percentage of individuals at BP goal (BP <130/80 mm Hg) were evaluated using a paired t test and McNemar test, respectively. Using Medicare claims data, a retrospective difference-in-differences analysis was conducted to assess the impact of an RPC hypertension program on total health care costs and resource utilization over a 12-month period following program activation when compared with a propensity score-matched control group. RESULTS: The clinical analysis included 7256 enrolled patients (mean ± SD age, 73±9 years; BP, 142/81±16/9 mm Hg; rural/underserved, 3957 [54.5%]) followed up for a mean ± SD of 49±20 weeks. The mean ± SD reduction in BP was 8/4±16/9 mm Hg (P<.001 for both systolic and diastolic BP) with an 89% relative increase in the number of patients at goal BP at follow-up (36.1% [2619 of 7256] vs 19.1% [1386]; P<.001). The cost and utilization analysis included 3936 enrolled and 7671 control patients who were followed up for an average of 10±2 months and had similar baseline demographic clinical, cost, and utilization data. The RPC hypertension program decreased total cost of care (-$57.89 per patient per month; P=.07) over 12 months, primarily due to a reduction in inpatient costs (-$87.50 per patient per month; P<.001) and admissions (-6 per 1000 patients per year vs +44 per 1000 patients per year, 26.5% reduction; P<.01). Clinical, costs, and utilization results were similar among patients living in rural/underserved areas. CONCLUSION: An RPC hypertension program can positively impact the management of hypertension in the United States by improving BP control while also reducing inpatient spending and admissions.
No takes yet. Share an insight, caveat, or question.
Feldman et al. (2026) conducted a cohort in Hypertension (n=7,256). Remote patient care (RPC) hypertension program vs. Baseline (clinical analysis) / Propensity score-matched control group (cost analysis) was evaluated on Percentage of individuals at BP goal (<130/80 mm Hg) (89% relative increase, p=<0.001). A nationwide remote patient care hypertension program increased the proportion of patients at blood pressure goal and reduced hospital admissions by 26.5%.
Synapse has enriched 10 related papers. Consider them for comparative context: